TY - JOUR
T1 - Assessment of vasodilator therapy in patients with severe congestive heart failure
T2 - Limitations of measurements of left ventricular ejection fraction and volumes
AU - Firth, Brian G.
AU - Dehmer, Gregory J.
AU - Markham, Roy V.
AU - Willerson, James T.
AU - Hillis, L. David
N1 - Funding Information:
From the Department of Internal Medicine (Cardiology Division), the University of Texas Health Science Center and Parkland Memorial Hospital, Dallas, Texas. This work was supported by lschemic SCOR Grant HL 17669 from the National Institutes of Health, Bethesda, Maryland, and the Harry S. Moss Heart Fund, Dallas, Texas. Manuscript received November 11. 1981; revised manuscript received April 13, 1982, accepted April 16, 1982. Address for reprints: Brian G. Firth, MD, DPhil, lschemic Heart Center, L5.134, University of Texas Health Science Center at Dallas, 5323 Harry Hines Boulevard, Dallas, Texas 75235.
PY - 1982/11
Y1 - 1982/11
N2 - Although noninvasive techniques are often used to assess the effect of vasodilator therapy in patients with congestive heart failure, it is unknown whether changes in noninvasively determined left ventricular ejection fraction, volume, or dimension reliably reflect alterations in intracardiac pressure and flow. Accordingly, we compared the acute effect of sodium nitroprusside on left ventricular volume and ejection fraction (determined scintigraphically) with its effect on intracardiac pressure and forward cardiac index (determined by thermodilution) in 12 patients with severe, chronic congestive heart failure and a markedly dilated left ventricle. Nitroprusside (infused at 1.3 ± 1.1 [mean ± standard deviation] μg/kg/min) caused a decrease in mean systemic arterial, mean pulmonary arterial and mean pulmonary capillary wedge pressure as well as a concomitant increase in forward cardiac index. Simultaneously, left ventricular end-diastolic and end-systolic volume indexes decreased, but the scintigraphically determined cardiac index did not change significantly. Left ventricular ejection fraction averaged 0.19 ± 0.05 before nitroprusside administration and increased by less than 0.05 units in response to nitroprusside in 11 of 12 patients. The only significant correlation between scintigraphically and invasively determined variables was that between the percent change in end-diastolic volume index and the percent change in pulmonary capillary wedge pressure (r = 0.68, p = 0.01). Although nitroprusside produced changes in scintigraphically determined left ventricular ejection fraction end-systolic volume index and cardiac index, these alterations bore no predictable relation to changes in intracardiac pressure, forward cardiac index, or vascular resistance. Furthermore, nitroprusside produced a considerably greater percent change in the invasively measured variables than in the scintigraphically determined ones.
AB - Although noninvasive techniques are often used to assess the effect of vasodilator therapy in patients with congestive heart failure, it is unknown whether changes in noninvasively determined left ventricular ejection fraction, volume, or dimension reliably reflect alterations in intracardiac pressure and flow. Accordingly, we compared the acute effect of sodium nitroprusside on left ventricular volume and ejection fraction (determined scintigraphically) with its effect on intracardiac pressure and forward cardiac index (determined by thermodilution) in 12 patients with severe, chronic congestive heart failure and a markedly dilated left ventricle. Nitroprusside (infused at 1.3 ± 1.1 [mean ± standard deviation] μg/kg/min) caused a decrease in mean systemic arterial, mean pulmonary arterial and mean pulmonary capillary wedge pressure as well as a concomitant increase in forward cardiac index. Simultaneously, left ventricular end-diastolic and end-systolic volume indexes decreased, but the scintigraphically determined cardiac index did not change significantly. Left ventricular ejection fraction averaged 0.19 ± 0.05 before nitroprusside administration and increased by less than 0.05 units in response to nitroprusside in 11 of 12 patients. The only significant correlation between scintigraphically and invasively determined variables was that between the percent change in end-diastolic volume index and the percent change in pulmonary capillary wedge pressure (r = 0.68, p = 0.01). Although nitroprusside produced changes in scintigraphically determined left ventricular ejection fraction end-systolic volume index and cardiac index, these alterations bore no predictable relation to changes in intracardiac pressure, forward cardiac index, or vascular resistance. Furthermore, nitroprusside produced a considerably greater percent change in the invasively measured variables than in the scintigraphically determined ones.
UR - http://www.scopus.com/inward/record.url?scp=0020414955&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0020414955&partnerID=8YFLogxK
U2 - 10.1016/0002-9149(82)90401-5
DO - 10.1016/0002-9149(82)90401-5
M3 - Article
C2 - 6291370
AN - SCOPUS:0020414955
SN - 0002-9149
VL - 50
SP - 954
EP - 959
JO - American Journal of Cardiology
JF - American Journal of Cardiology
IS - 5
ER -